Loading...
Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
Antibody directed chemotherapy (ADC) takes advantage of the selectivity of the monoclonal antibody to increase the efficacy of the chemotherapeutic agent, while reducing toxicity. Previously we described three nab-paclitaxel (Abraxane) nanoparticles coated with commercial monoclonal antibodies. Iden...
Saved in:
| Published in: | Sci Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5670201/ https://ncbi.nlm.nih.gov/pubmed/29101359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-15251-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|